Home \ Projects \ Development of Biodefence Capabilities Project
Project

Development of Biodefence Capabilities Project

The aim of the project is to design and develop potential therapeutics against Risk Group 4 (RG4) agents or unknown pathogens in less than 3 months through advanced technology, such as aptamers, gene editing systems, and nanotechnology. The long-term goal is to develop effective therapeutics to be deployed to first responder Mexican entities and Latin American countries with limited response capacity.

Risk Area(s) covered

Activities

Beneficiary Countries

Beneficiary Regions

Budget

 USD

Status

Active
Start Date: 
End Date: 

ASI Database Release

Providers and Implementers ?

Related Projects & Programs

Contacts

No Contacts Found

Scroll to Top